Gainers
Evelo Biosciences, Inc. (NASDAQ: EVLO) shares gained 192.8% to $0.2427 in pre-market trading. Evelo Biosciences was granted U.S. patent #11672834 for "Prebiotic Compositions And Methods Of Use Thereof For Modulation Of The Microbiome."
Advancements May Result in Ability to Treat a Broader Patient Population with Immune DisordersPHOENIX, May 22, 2023 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the
Creative Medical Technology Holdings Inc (NASDAQ:CELZ) announced positive topline pilot study results for the StemSpine procedure using AlloStem to treat…